Badiango, James .

HRN: 24-90-72  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/09/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/09/2026
03/16/2026
IV
375mg
Q6
Pcap C
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: